Skip to main content
Editorial
Should comparative effectiveness research ignore industry-funded data?
- Adam G Dunn and
- Enrico Coiera
pp317–320
Published Online:2 October 2014
Why are patients uncertain about the human papillomavirus vaccine's effectiveness?
- Kassandra I Alcaraz and
- Lauren D Arnold
pp321–323
Published Online:2 October 2014
News
News & Views in ... Journal of Comparative Effectiveness Research
pp325–327
Published Online:2 October 2014
From Methods to Policy
Pay for quality: how much pay for how much quality?
- Robert W Dubois
pp329–330
Published Online:2 October 2014
Priority Paper Evaluation
Continuous infusion of levodopa–carbidopa intestinal gel in Parkinson's disease
- Lalitha N Guthikonda,
- Kelly E Lyons, and
- Rajesh Pahwa
pp331–333
Published Online:2 October 2014
Short Communication
Impact of extended-release quetiapine fumarate on hospitalization length and cost in schizophrenia and bipolar disorder patients: a retrospective, hospital-based, US-cohort analysis
- Julie C Locklear,
- Peter Wahlqvist,
- Urban Gustafsson,
- Mattias Udd,
- Liberty Fajutrao, and
- Hans Eriksson
pp335–344
Published Online:2 October 2014
Research Article
Using indirect comparisons to compare interventions within a Cochrane review: a tool for comparative effectiveness research
- Maria Agapova,
- Emily B Devine,
- Hiep Nguyen,
- Fredric M Wolf, and
- Lurdes YT Inoue
pp345–357
Published Online:2 October 2014
Implications of different laboratory-based incident diabetic kidney disease definitions on comparative effectiveness studies
- Emily B Schroeder,
- Glenn K Goodrich,
- Katherine M Newton,
- Julie A Schmittdiel, and
- Marsha A Raebel
pp359–369
Published Online:2 October 2014
Analysis of the influence of recent reforms in China: cardiovascular and cerebrovascular medicines as a case history to provide future direction
- Wenjie Zeng,
- Junjie Zhen,
- Mengying Feng,
- Stephen M Campbell,
- Alexander E Finlayson, and
- Brian Godman
pp371–386
Published Online:2 October 2014
A comparison of outcomes for early oropharyngeal cancers treated with single-modality surgery versus radiotherapy
- Vladimir Valakh,
- Curtis Miyamoto,
- Katsiaryna Mazurenka, and
- Jeffrey C Liu
pp387–397
Published Online:2 October 2014
Perspective
Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders
- Michael Schlander,
- Silvio Garattini,
- Søren Holm,
- Peter Kolominsky-Rabas,
- Erik Nord,
- Ulf Persson,
- Maarten Postma,
- Jeff Richardson,
- Steven Simoens,
- Oriol de Solà Morales,
- Keith Tolley, and
- Mondher Toumi
pp399–422
Published Online:2 October 2014
Review
Composite scores in comparative effectiveness research: counterbalancing parsimony and dimensionality in patient-reported outcomes
- Carolyn E Schwartz and
- Donald L Patrick
pp423–433
Published Online:2 October 2014
Impact of Sativex® on quality of life and activities of daily living in patients with multiple sclerosis spasticity
- Rafael Arroyo,
- Carlos Vila, and
- Kerry L Dechant
pp435–444
Published Online:2 October 2014